The Landscape of Cancer Vaccines and Research Platforms:
The Cutting Edge
Exclusive online event
Deep Pharma Intelligence held a virtual event (November 23), which was a unique opportunity share our findings from a unique market study revealing R&D platforms for developing therapeutic cancer vaccines, the key players in each category, the science behind the development, and case studies illustrating opportunities and challenges of each research strategy.
We presented our categorization of the 5 platforms — including relatively mainstream strategies — Neoantigen Platform, Tumor-associated Antigens Platform, Cellular Platform, and Oncolytic Viruses Platform — and the latest breakthrough and a potentially disruptive research strategy — Antigenic Essence Platform.